Product Images Insulin Glargine

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 34 images provide visual information about the product associated with Insulin Glargine NDC 83257-014 by Biocon Biologics Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Glucose-Lowering Effect Over 24 Hours in Patients with Type 1 Diabetes - image 01

Glucose-Lowering Effect Over 24 Hours in Patients with Type 1 Diabetes - image 01

Step 1 - image 02

Step 1 - image 02

Step 2 - image 03

Step 2 - image 03

Step 3 - image 04

Step 3 - image 04

Step 4 - image 05

Step 4 - image 05

Step 5 - image 06

Step 5 - image 06

Step 7 - image 07

Step 7 - image 07

Step 8 - image 08

Step 8 - image 08

Places to inject - image 09

Places to inject - image 09

Upper arms: This refers to the area of the arms above the elbows. It includes the biceps and triceps muscles and is a common target for exercise and muscle development. Front and side of thigh: This refers to the areas of the leg that are located at the front and side, specifically the quadriceps muscles in the front and the hamstrings and adductors on the sides. These muscle groups are important for leg strength and stability.*

Get to know your pen - image 10

Get to know your pen - image 10

This document appears to be describing a pen cartridge pen used for injections. It includes information about the expiration date, dose measurement, and injection process. The pen features a cap holder, body, pointer, and button for administering the dose. There is also a rubber seal and a window selector for selecting the desired insulin dose. Please note that the pen needle is not included.*

Figure a - image 11

Figure a - image 11

Figure b - image 12

Figure b - image 12

Figure c - image 13

Figure c - image 13

Figure d - image 14

Figure d - image 14

Figure e - image 15

Figure e - image 15

Figure f - image 16

Figure f - image 16

Figure g - image 17

Figure g - image 17

Figure h - image 18

Figure h - image 18

Figure i - image 19

Figure i - image 19

Figure j - image 20

Figure j - image 20

Figure k - image 21

Figure k - image 21

Figure l - image 22

Figure l - image 22

Figure m - image 23

Figure m - image 23

Figure n - image 24

Figure n - image 24

Figure o - image 25

Figure o - image 25

Figure p - image 26

Figure p - image 26

Figure q - image 27

Figure q - image 27

Figure r - image 28

Figure r - image 28

Figure s - image 29

Figure s - image 29

Figure t - image 30

Figure t - image 30

Figure u - image 31

Figure u - image 31

Figure v - image 32

Figure v - image 32

Insulin Glargine-yfgn Injection, 100 units/mL (U-100) - Pen - image 33

Insulin Glargine-yfgn Injection, 100 units/mL (U-100) - Pen - image 33

Insulin Glargine-yfgn Injection, 100 units/mL (U-100) - Vial - image 34

Insulin Glargine-yfgn Injection, 100 units/mL (U-100) - Vial - image 34

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.